Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background: Etiological research of depression and anxiety disorders has been hampered by diagnostic heterogeneity. In order to address this, researchers have tried to identify more homogeneous patient subgroups. This work has predominantly focused on explaining interpersonal heterogeneity based on clinical features (i.e. symptom profiles). However, to explain interpersonal variations in underlying pathophysiological mechanisms, it might be more effective to take biological heterogeneity as the point of departure when trying to identify subgroups. Therefore, this study aimed to identify data-driven subgroups of patients based on biomarker profiles. Methods: Data of patients with a current depressive and/or anxiety disorder came from the Netherlands Study of Depression and Anxiety, a large, multi-site naturalistic cohort study (n= 1460). Thirty-six biomarkers (e.g. leptin, brain-derived neurotrophic factor, tryptophan) were measured, as well as sociodemographic and clinical characteristics. Latent class analysis of the discretized (lower 10%, middle, upper 10%) biomarkers were used to identify different patient clusters. Results: The analyses resulted in three classes, which were primarily characterized by different levels of metabolic health: ‘lean’ (21.6%), ‘average’ (62.2%) and ‘overweight’ (16.2%). Inspection of the classes’ clinical features showed the highest levels of psychopathology, severity and medication use in the overweight class. Conclusions: The identified classes were strongly tied to general (metabolic) health, and did not reflect any natural cutoffs along the lines of the traditional diagnostic classifications. Our analyses suggested that especially poor metabolic health could be seen as a distal marker for depression and anxiety, suggesting a relationship between the ‘overweight’ subtype and internalizing psychopathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · cited 3×
“Depression symptom severity was measured with the 30-item Inventory of Depressive Symptomatology Self Report (IDS-SR) (Rush et al., 1996).”
BackgroundMethodInfluentialDiscovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800702 · Cited by 1,066 · cited 2×
“A heart rate recording was performed with the Vrije Universiteit Ambulatory Monitoring System (Cuijpers et al., 2013) (VU-AMS).”
MethodKapur, S., Phillips, A. G., & Insel, T. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.105 · Cited by 980 · cited 1×
“monoamine deficiency) have limited validity (Kendell and Jablensky, 2003; Hasler, 2010; Kapur et al., 2012).”
BackgroundCooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.20.1.2 · Cited by 895
Lamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.144 · Cited by 691
Self-citationPathophysiology of depression: do we have any solid evidence of interest to clinicians?
HASLER, G. (2010) · World Psychiatry · doi:10.1002/j.2051-5545.2010.tb00298.x · Cited by 604 · cited 1×
“monoamine deficiency) have limited validity (Kendell and Jablensky, 2003; Hasler, 2010; Kapur et al., 2012).”
BackgroundCuijpers, P., van Straten, A., Bohlmeijer, E., Hollon, S. D., & Andersson, G. (2010) · Psychological Medicine · doi:10.1017/s0033291709006114 · Cited by 533
Licht, C. M. M., de Geus, E. J. C., Zitman, F. G., Hoogendijk, W. J. G., van Dyck, R., & Penninx, B. W. J. H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.12.1358 · Cited by 379
Self-citationPersonalized Medicine for Depression: Can We Match Patients With Treatments?
Simon, G. E., & Perlis, R. H. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09111680 · Cited by 365 · cited 1×
“Identification of more homogeneous biomarker-based subtypes in the patient population could help to gain more insight into patient-specific etiological mechanisms and to better target treatments to those that are likely to benefit (Meyer and Ginsburg, 2002; Bartova et al., 2010; Leuchter et al., 2010; Simon and Perlis…”
BackgroundThe heterogeneity of “major depression”
GOLDBERG, D. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00061.x · Cited by 335 · cited 1×
“The overlap between depressive and anxiety symptoms and disorders is the rule rather than the exception, and much of the same treatments are currently used for patients in both diagnostics categories (Nutt et al., 2002; Hettema, 2008; Goldberg, 2011).”
BackgroundMeta-review of depressive subtyping models
Harald, B., & Gordon, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.015 · Cited by 328 · cited 1×
“Unfortunately, more homogeneous clinical subtypes have been shown to be weakly associated with etiology, the course of illness, and treatment response (Baumeister and Parker, 2012).”
BackgroundVancampfort, D., Correll, C. U., Wampers, M., Sienaert, P., Mitchell, A. J., De Herdt, A., Probst, M., Scheewe, T. W., & De Hert, M. (2014) · Psychological Medicine · doi:10.1017/s0033291713002778 · Cited by 317 · cited 3×
“, 2010), and with results from large-scale meta-analyses (Blaine, 2008; Luppino et al., 2010; Sardinha and Nardi, 2014; Vancampfort et al., 2014; Ghanei Gheshlagh et al., 2015; Mannan et al., 2016).”
BackgroundResultMannan, M., Mamun, A., Doi, S., & Clavarino, A. (2016) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.12.008 · Cited by 280
Personalized medicine in psychiatry: problems and promises
Ozomaro, U., Wahlestedt, C., & Nemeroff, C. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-132 · Cited by 270
Milaneschi, Y., Lamers, F., Bot, M., Drent, M. L., & Penninx, B. W. J. H. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.023 · Cited by 209
Self-citationVan Reedt Dortland, A. K. B., Giltay, E. J., Van Veen, T., Zitman, F. G., & Penninx, B. W. J. H. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01565.x · Cited by 191
Self-citationVogelzangs, N., Beekman, A. T., van Reedt Dortland, A. K., Schoevers, R. A., Giltay, E. J., de Jonge, P., & Penninx, B. W. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.9 · Cited by 133
Self-citationGlobal burden of disease studies: implications for mental and substance use disorders
Whiteford, H., Ferrari, A., & Degenhardt, L. (2016) · Health Affairs · doi:10.1377/hlthaff.2016.0082 · Cited by 130
Personalized Psychotherapy for Adult Depression: A Meta-Analytic Review
Cuijpers, P., Ebert, D. D., Acarturk, C., Andersson, G., & Cristea, I. A. (2016) · Behavior Therapy · doi:10.1016/j.beth.2016.04.007 · Cited by 128
Roest, A. M., de Jonge, P., Williams, C. D., de Vries, Y. A., Schoevers, R. A., & Turner, E. H. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.15 · Cited by 101
Self-citationQuak, J., Doornbos, B., Roest, A. M., Duivis, H. E., Vogelzangs, N., Nolen, W. A., Penninx, B. W. J. H., Kema, I. P., & de Jonge, P. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.013 · Cited by 98 · cited 1×
“Both inflammation and degradation of tryptophan along the kynurenine pathway have been found to be associated with depression in this sample (Lamers et al., 2013; Quak et al., 2014).”
BackgroundSelf-citationPatas, K., Penninx, B. W. J. H., Bus, B. A. A., Vogelzangs, N., Molendijk, M. L., Elzinga, B. M., Bosker, F. J., & Oude Voshaar, R. C. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.10.007 · Cited by 80
Self-citationDepression: The Shroud of Heterogeneity
Monroe, S. M., & Anderson, S. F. (2015) · Current Directions in Psychological Science · doi:10.1177/0963721414568342 · Cited by 68
Cited by
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
“It might be worthwhile to use biological differences as a springboard for defining depression subtypes based on biomarker profile analysis utilizing latent class analysis [445].”
MethodTazawa, Y., Liang, K.-C., Yoshimura, M., Kitazawa, M., Kaise, Y., Takamiya, A., Kishi, A., Horigome, T., Mitsukura, Y., Mimura, M., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03274 · Cited by 101
“Because there is a lack of quantifiable biological markers in psychiatry (Beijers et al., 2019), the ability to non-invasively collect data from wearable devices can improve diagnoses and evaluations of illness severity (Dogan et al.”
BackgroundKim, J. S., Wang, B., Kim, M., Lee, J., Kim, H., Roh, D., Lee, K. H., Hong, S.-B., Lim, J. S., Kim, J.-W., et al. (2023) · JMIR Formative Research · doi:10.2196/45991 · Cited by 25
“However, recall bias in reporting mood symptoms [4], subjectivity of self-reported symptoms, and the lack of quantifiable markers [5] contribute to the difficulty in treating depression in adolescents.”
Background
Metadata
- Authors
- Beijers, L., Wardenaar, K. J., Bosker, F. J., Lamers, F., van Grootheest, G., de Boer, M. K., Penninx, B. W. J. H., & Schoevers, R. A.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2018-06-04
- Volume
- 49
- Issue
- 4
- Pages
- 617-627
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2805419645
- Cited by
- 37
- References
- 25
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.